Tuberculosis

MENLO PARK, Calif. — September 28, 2026 AN2 Therapeutics, Inc. announced that the Gates Foundation has extended funding supporting...

Salt Lake City, Utah, U.S., September 17, 2026 Co-Diagnostics, Inc., a molecular diagnostics company developing technologies for infectious disease...

SALT LAKE CITY, July 22, 2026 Co-Diagnostics, Inc. has announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd.,...

KIGALI, Rwanda, July 20, 2026 Akagera Medicines, Inc. has announced positive first-in-human Phase 1 results for AKG-100, its investigational...

BASEL, Switzerland, July 9, 2026 Roche has announced that its Elecsys IGRA TB blood test has received CE Mark...